| abstract |
The present invention relates to bipodal peptide binders (BPBs) that specifically bind to CD7 and uses thereof. The CD7-BPB of the present invention exhibits very low levels (eg, nM levels) of K d values, resulting in very high affinity to the target. The CD7-BPB of the present invention can be very useful for targeting cells expressing CD7. The CD7-BPB of the present invention, in combination with other structures (preferably liposomes), allows for the delivery of the desired drug to cells expressing CD7 (preferably T cells). |